Single-dose oral anti-arrhythmic drugs for cardioversion of recent-onset atrial fibrillation: a systematic review and network meta-analysis of randomized controlled trials

Single-dose oral anti-arrhythmic drugs for cardioversion of recent-onset atrial fibrillation: a systematic review and network meta-analysis of randomized controlled trials

Abstract Aims Single oral dose anti-arrhythmic drugs (AADs) are used to cardiovert recent-onset atrial fibrillation (AF); however, the optimal agent is uncertain. Methods We performed a systematic review and network meta-analysis of randomized trials testing single oral dose AADs vs. any comparator...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Europace (London, England) England), 2021-08, Vol.23 (8), p.1200-1210
Hauptverfasser: Ibrahim, Omar A, Belley-Côté, Emilie P, Um, Kevin J, Baranchuk, Adrian, Benz, Alexander P, Dalmia, Shreyash, Wang, Chang N, Alhazzani, Waleed, Conen, David, Devereaux, P J, Whitlock, Richard P, Healey, Jeff S, McIntyre, William F
Format: Artikel
Sprache:eng
Schlagworte:
Amiodarone
Cardiac arrhythmia
Cardioversion
Clinical trials
Congestive heart failure
Drug dosages
Fibrillation
Heart diseases
Heart rate
Hypotension
Ischemia
Meta-analysis
Placebos
Systematic review
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Abstract Aims Single oral dose anti-arrhythmic drugs (AADs) are used to cardiovert recent-onset atrial fibrillation (AF); however, the optimal agent is uncertain. Methods We performed a systematic review and network meta-analysis of randomized trials testing single oral dose AADs vs. any comparator to cardiovert AF
ISSN:1099-5129
1532-2092
DOI:10.1093/europace/euab014